Adalimumab in JIA-associated Uveitis Stopping Trial
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Murdoch Children'S Research Institute
Parkville, Victoria, Australia
- University Hospitals Bristol and Weston
Bristol, United Kingdom
- Cambridge University Hospital
Cambridge, United Kingdom
- University Hospitals, Leicester
Leicester, United Kingdom
- Alder Hey Children'S Hospital
Liverpool, United Kingdom
- Great Ormond Street Hospital
London, United Kingdom
- Manchester University Nhs Foundation Trust
Manchester, United Kingdom
- Great North Children'S Hospital
Newcastle upon Tyne, United Kingdom
- Norfolk and Norwich University Hospital
Norwich, United Kingdom
- Sheffield Children'S Hospital
Sheffield, United Kingdom
- University of California, Davis
Sacramento, California, United States
- University of California, San Francisco
San Francisco, California, United States
- University of Colorado Denver
Aurora, Colorado, United States
- Colorado Retina Associates
Lakewood, Colorado, United States
- University of Miami
Miami, Florida, United States
- Children'S Mercy Hospital
Kansas City, Missouri, United States
- Cincinnati Children'S Hospital
Cincinnati, Ohio, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- University of Texas, Austin
Austin, Texas, United States
- University of Utah Health
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Mar 2020
- Primary completion
- 23 Jan 2025
- Completion
- 3 Apr 2025
- Last update posted
- 11 May 2025
- Registered enrollment
- 87
- Registry id
- NCT03816397
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.